Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ixazomib maintenance in NDMM non-SCT
NCT02312258Phase 3Completed
- Sponsor
- Takeda
- Start
- Apr 2015
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 35
01
Overview
A Phase 3 trial of ixazomib in multiple myeloma (MM), sponsored by Takeda. Started Apr 2015; status: completed.
02
Drugs
ixazomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT02312258.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02312258.